Global Ursodeoxycholic Acid Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Ursodeoxycholic Acid market size was valued at US$ 523 million in 2024 and is forecast to a readjusted size of USD 988 million by 2031 with a CAGR of 9.5% during review period.

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.

The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA as a key component in manufacturing medications to address these conditions.

One of the major challenges faced by the UDCA API market is the high cost of production, which can limit accessibility, especially in developing regions. The complex extraction and synthesis process of UDCA contributes to its expensive manufacturing, making it difficult for pharmaceutical companies to offer cost-effective treatments. Additionally, regulatory hurdles and stringent quality standards for drug approval add further pressure on manufacturers, which may slow down market growth.

APAC is the largest consumption place, with a consumption market share nearly 52% in 2023. Following APAC, Europe is the second largest consumption place with the consumption market share of 30%.

Global key Ursodeoxycholic Acid players cover ICE, Dipharma Francis, Daewoong Chemical, Zhongshan Bailing, PharmaZell GmbH, Suzhou Tianlv, Yun Gang Bio, Grindeks, etc. In terms of revenue, the global five largest companies occupied for a share nearly 72% in 2023.

This report is a detailed and comprehensive analysis for global Ursodeoxycholic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Ursodeoxycholic Acid market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Ursodeoxycholic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Ursodeoxycholic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Ursodeoxycholic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Ursodeoxycholic Acid

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Ursodeoxycholic Acid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan Bailing, Dipharma Francis, Grindeks, Suzhou Tianlv, Yun Gang Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Ursodeoxycholic Acid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Synthetic UDCA
Extraction UDCA

Market segment by Application
Pharmacy
Health Products

Major players covered
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan Bailing
Dipharma Francis
Grindeks
Suzhou Tianlv
Yun Gang Bio

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ursodeoxycholic Acid product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid, with price, sales quantity, revenue, and global market share of Ursodeoxycholic Acid from 2020 to 2025.

Chapter 3, the Ursodeoxycholic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ursodeoxycholic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ursodeoxycholic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Ursodeoxycholic Acid.

Chapter 14 and 15, to describe Ursodeoxycholic Acid sales channel, distributors, customers, research findings and conclusion.